BIO-activated opioid drugs with unprecedented oral and non-oral abuse-resistance
Ended Project Grant Awarded Last action
- Award ID
- R44DA037900
- Recipient
-
Elysium Therapeutics, Inc. UEI CQ2LJLATAKH9
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,761,961
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- Danville, CA 94506, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $2,742 | |
| Amendment | $0 | |
| Amendment | $1,541,693 | |
| Original award | $217,526 |
Quick answers
Who received award R44DA037900?
R44DA037900 was awarded to Elysium Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on August 15, 2014.
How much is award R44DA037900 worth?
$1,761,961 has been obligated on R44DA037900.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award